<SUBMISSION>
<SECRELEASE-DATETIME> 20240405-160001 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME> 20240405-160000 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME> 20240405-155923 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER> 0000814133-24-000068
<TYPE> SC 13G/A
<PUBLIC-DOCUMENT-COUNT> 1
<FILING-DATE> 20240405
<DATE-OF-FILING-DATE-CHANGE> 20240405
|
<SUBJECT-COMPANY>
<COMPANY-DATA>
<CONFORMED-NAME> SANGAMO THERAPEUTICS, INC
<CIK> 0001001233
<ASSIGNED-SIC> 2836
<ORGANIZATION-NAME> 03 Life Sciences
<IRS-NUMBER> 680359556 ⇒ 68-0359556
<STATE-OF-INCORPORATION> DE
<FISCAL-YEAR-END> 1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE> SC 13G/A
<ACT> 34
<FILE-NUMBER> 005-59049
<FILM-NUMBER> 24826366
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1> 501 CANAL BLVD.
<CITY> RICHMOND
<STATE> CA
<ZIP> 94084
<PHONE> 5109706000
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1> 501 CANAL BLVD.
<CITY> RICHMOND
<STATE> CA
<ZIP> 94084
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME> SANGAMO BIOSCIENCES INC
<DATE-CHANGED> 20000208
</FORMER-COMPANY>
</SUBJECT-COMPANY>
|
<FILED-BY>
<COMPANY-DATA>
<CONFORMED-NAME> WASATCH ADVISORS LP
<CIK> 0000814133
<ORGANIZATION-NAME>
<IRS-NUMBER> 870319391 ⇒ 87-0319391
<STATE-OF-INCORPORATION> DE
<FISCAL-YEAR-END> 1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE> SC 13G/A
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1> 505 WAKARA WAY
<STREET2> 3RD FLOOR
<CITY> SALT LAKE CITY
<STATE> UT
<ZIP> 84108
<PHONE> 8015330777
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1> 505 WAKARA WAY
<STREET2> 3RD FLOOR
<CITY> SALT LAKE CITY
<STATE> UT
<ZIP> 84108
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME> WASATCH ADVISORS INC
<DATE-CHANGED> 19990611
</FORMER-COMPANY>
</FILED-BY>
|
<DOCUMENT>
<TYPE> SC 13G/A
<SEQUENCE> 1
<FILENAME> sgmo424.txt
<TEXT>
Show <TEXT>: 55 lines (widest: 76 characters) - 3K bytes
</TEXT>
</DOCUMENT>
|
</SUBMISSION> |
| ↑Top |
